{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:11:45Z","timestamp":1789726305581,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Older adults (aged 65\u2009years and above) constitute the fastest growing population cohort in the western world. There is increasing evidence that the burden of infections disproportionately affects older adults, and hence this vulnerable population is frequently exposed to antimicrobials. There is currently no systematic review summarising the evidence for organ injury risk among older adults following antimicrobial exposure. This systematic review and meta-analysis examined the relationship between antimicrobial exposure and organ injury in older adults.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>We searched for original research articles in PubMed, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/embase.com\">Embase.com<\/jats:ext-link>, Web of Science core collection, Web of Science BIOSIS citation index, Scopus, Cochrane Central Register of Controlled Trials, ProQuest, and PsycINFO databases, using key words in titles and abstracts, and using MeSH terms. We searched for all available articles up to 31 May 2021. After removing duplicates, articles were screened for inclusion into or exclusion from the study by two reviewers. The Newcastle-Ottawa scale was used to assess the risk of bias for cohort and case-control studies. We explored the heterogeneity of the included studies using the Q test and I<jats:sup>2<\/jats:sup> test and the publication bias using the funnel plot and Egger\u2019s test. The meta-analyses were performed using the OpenMetaAnalyst software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The overall absolute risks of acute kidney injury among older adults prescribed aminoglycosides, glycopeptides, and macrolides were 15.1% (95% CI: 12.8\u201317.3), 19.1% (95% CI: 15.4\u201322.7), and 0.3% (95% CI: 0.3\u20130.3), respectively. Only 3 studies reported antimicrobial associated drug-induced liver injury. Studies reporting on the association of organ injury and antimicrobial exposure by age or duration of treatment were too few to meta-analyse. The funnel plot and Egger\u2019s tests did not indicate evidence of publication bias.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Older adults have a significantly higher risk of sustaining acute kidney injury when compared to the general adult population. Older adults prescribed aminoglycosides have a similar risk of acute kidney injury to the general adult population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-021-02512-3","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T17:02:40Z","timestamp":1635786160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Risk of antimicrobial-associated organ injury among the older adults: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Tichawona","family":"Chinzowu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipan","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S.","family":"Nishtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"issue":"3","key":"2512_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1556\/EuJMI.1.2011.3.2","volume":"1","author":"S Augustine","year":"2011","unstructured":"Augustine S, Bonomo RA. Taking stock of infections and antibiotic resistance in the elderly and long-term care facilities: a survey of existing and upcoming challenges. Eur J Microbiol Immunol (Bp). 2011;1(3):190\u20137. https:\/\/doi.org\/10.1556\/EuJMI.1.2011.3.2.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"2512_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fmed.2019.00118","volume":"6","author":"M Esme","year":"2019","unstructured":"Esme M, Topeli A, Yavuz BB, Akova M. Infections in the Elderly Critically-Ill Patients. Front Med (Lausanne). 2019;6:118.","journal-title":"Front Med (Lausanne)"},{"key":"2512_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2147\/CIA.S133640","volume":"13","author":"A Giarratano","year":"2018","unstructured":"Giarratano A, Green SE, Nicolau DP. Review of antimicrobial use and considerations in the elderly population. Clin Interv Aging. 2018;13:657\u201367. https:\/\/doi.org\/10.2147\/CIA.S133640.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"2512_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1365-2125.2003.01953.x","volume":"57","author":"K Martin","year":"2004","unstructured":"Martin K, B\u00e9gaud B, Latry P, Miremont-Salam\u00e9 G, Fourrier A, Moore N. Differences between clinical trials and postmarketing use. Br J Clin Pharmacol. 2004;57(1):86\u201392. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01953.x.","journal-title":"Br J Clin Pharmacol"},{"key":"2512_CR5","unstructured":"Wells GA SB, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [cited 2020 01 October]. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"7414","key":"2512_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ."},{"issue":"10","key":"2512_CR7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046\u201355. https:\/\/doi.org\/10.1016\/S0895-4356(01)00377-8.","journal-title":"J Clin Epidemiol"},{"issue":"7109","key":"2512_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ."},{"issue":"3","key":"2512_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"key":"2512_CR10","doi-asserted-by":"publisher","unstructured":"Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational Back-end. J Stat Softw. 2012;49(5). https:\/\/doi.org\/10.18637\/jss.v049.i05.","DOI":"10.18637\/jss.v049.i05"},{"issue":"9","key":"2512_CR11","doi-asserted-by":"publisher","first-page":"e1002652","DOI":"10.1371\/journal.pmed.1002652","volume":"15","author":"H Ahmed","year":"2018","unstructured":"Ahmed H, Farewell D, Francis NA, Paranjothy S, Butler CC. Risk of adverse outcomes following urinary tract infection in older people with renal impairment: retrospective cohort study using linked health record data. PLoS Med. 2018;15(9):e1002652. https:\/\/doi.org\/10.1371\/journal.pmed.1002652.","journal-title":"PLoS Med"},{"issue":"2","key":"2512_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/106002800303700203","volume":"37","author":"AM Baciewicz","year":"2003","unstructured":"Baciewicz AM, Sokos DR, Cowan RI. Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharmacother. 2003;37(2):182\u20136. https:\/\/doi.org\/10.1177\/106002800303700203.","journal-title":"Ann Pharmacother"},{"issue":"12","key":"2512_CR13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.5588\/ijtld.16.0370","volume":"20","author":"RJ Bright-Thomas","year":"2016","unstructured":"Bright-Thomas RJ, Gondker AR, Morris J, Ormerod LP. Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period. Int J Tuberc Lung Dis. 2016;20(12):1621\u20134. https:\/\/doi.org\/10.5588\/ijtld.16.0370.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"2512_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40121-013-0022-6","volume":"2","author":"JJ Carreno","year":"2013","unstructured":"Carreno JJ, Jaworski A, Kenney RM, Davis SL. Comparative incidence of nephrotoxicity by age group among adult patients receiving Vancomycin. Infect Dis Ther. 2013;2(2):201\u20138. https:\/\/doi.org\/10.1007\/s40121-013-0022-6.","journal-title":"Infect Dis Ther"},{"issue":"12","key":"2512_CR15","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.injury.2012.08.005","volume":"43","author":"P Craig","year":"2012","unstructured":"Craig P, Starks I, Bancroft G, Roberts P. Is prophylactic gentamicin associated with acute kidney injury in patients undergoing surgery for fractured neck of femur? Injury. 2012;43(12):2152\u20135. https:\/\/doi.org\/10.1016\/j.injury.2012.08.005.","journal-title":"Injury."},{"key":"2512_CR16","doi-asserted-by":"publisher","first-page":"k341","DOI":"10.1136\/bmj.k341","volume":"360","author":"E Crellin","year":"2018","unstructured":"Crellin E, Mansfield KE, Leyrat C, Nitsch D, Douglas IJ, Root A, et al. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. BMJ. 2018;360:k341. https:\/\/doi.org\/10.1136\/bmj.k341.","journal-title":"BMJ."},{"issue":"5","key":"2512_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/ageing\/afu023","volume":"43","author":"T Fraisse","year":"2014","unstructured":"Fraisse T, Gras Aygon C, Paccalin M, Vitrat V, De Wazieres B, Baudoux V, et al. Aminoglycosides use in patients over 75 years old. Age Ageing. 2014;43(5):676\u201381. https:\/\/doi.org\/10.1093\/ageing\/afu023.","journal-title":"Age Ageing"},{"issue":"23","key":"2512_CR18","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1001\/jama.2013.282426","volume":"310","author":"S Gandhi","year":"2013","unstructured":"Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, et al. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. 2013;310(23):2544\u201353. https:\/\/doi.org\/10.1001\/jama.2013.282426.","journal-title":"JAMA."},{"issue":"2","key":"2512_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000496484","volume":"49","author":"G Gyamlani","year":"2019","unstructured":"Gyamlani G, Potukuchi PK, Thomas F, Akbilgic O, Soohoo M, Streja E, et al. Vancomycin-associated acute kidney injury in a large veteran population. Am J Nephrol. 2019;49(2):133\u201342. https:\/\/doi.org\/10.1159\/000496484.","journal-title":"Am J Nephrol"},{"issue":"6","key":"2512_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/jcpt.12203","volume":"39","author":"RG Hall","year":"2014","unstructured":"Hall RG, Blaszczyk AT, Thompson KA, Brouse SD, Giuliano CA, Frei CR, et al. Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Clin Pharm Ther. 2014;39(6):653\u20137. https:\/\/doi.org\/10.1111\/jcpt.12203.","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"2512_CR21","first-page":"349","volume":"21","author":"M Huang","year":"2018","unstructured":"Huang M, Wu H, Zhou J, Xu M, Zhou S. Efficacy of Vancomycin on gram-positive bacterial infection in elderly critical patients and risk factors associated with nephrotoxicity. Arch Iran Med. 2018;21(8):349\u201355.","journal-title":"Arch Iran Med"},{"issue":"12","key":"2512_CR22","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1248\/bpb.b14-00362","volume":"37","author":"F Karino","year":"2014","unstructured":"Karino F, Nishimura N, Ishihara N, Moriyama H, Miura K, Hamaguchi S, et al. Nephrotoxicity induced by piperacillin\u2013tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia. Biol Pharm Bull. 2014;37(12):1971\u20136. https:\/\/doi.org\/10.1248\/bpb.b14-00362.","journal-title":"Biol Pharm Bull"},{"issue":"5\u20136","key":"2512_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000381783","volume":"95","author":"Y Liu","year":"2015","unstructured":"Liu Y, Yin Y, Liu XZ, Yao HJ, Li LX, Chen JH, et al. Retrospective analysis of vancomycin nephrotoxicity in elderly Chinese patients. Pharmacology. 2015;95(5\u20136):279\u201384. https:\/\/doi.org\/10.1159\/000381783.","journal-title":"Pharmacology."},{"issue":"3","key":"2512_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1503\/cmaj.140950","volume":"187","author":"DQ Li","year":"2015","unstructured":"Li DQ, Kim R, McArthur E, Fleet JL, Bailey DG, Juurlink D, et al. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. CMAJ. 2015;187(3):174\u201380. https:\/\/doi.org\/10.1503\/cmaj.140950.","journal-title":"CMAJ."},{"key":"2512_CR25","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2147\/CIA.S50238","volume":"8","author":"F Mizokami","year":"2013","unstructured":"Mizokami F, Shibasaki M, Yoshizue Y, Noro T, Mizuno T, Furuta K. Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia. Clin Interv Aging. 2013;8:1015\u201321. https:\/\/doi.org\/10.2147\/CIA.S50238.","journal-title":"Clin Interv Aging"},{"key":"2512_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.rmed.2019.09.004","volume":"157","author":"CS Noh","year":"2019","unstructured":"Noh CS, Kim HI, Choi H, Kim Y, Kim CH, Choi JH, et al. Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older. Respir Med. 2019;157:52\u20138. https:\/\/doi.org\/10.1016\/j.rmed.2019.09.004.","journal-title":"Respir Med"},{"issue":"11","key":"2512_CR27","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1093\/jac\/dkw296","volume":"71","author":"LZ Ong","year":"2016","unstructured":"Ong LZ, Tambyah PA, Lum LH, Low ZJ, Cheng I, Murali TM, et al. Aminoglycoside-associated acute kidney injury in elderly patients with and without shock. J Antimicrob Chemother. 2016;71(11):3250\u20137. https:\/\/doi.org\/10.1093\/jac\/dkw296.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2512_CR28","doi-asserted-by":"publisher","first-page":"e0175688","DOI":"10.1371\/journal.pone.0175688","volume":"12","author":"K Pan","year":"2017","unstructured":"Pan K, Ma L, Xiang Q, Li X, Li H, Zhou Y, et al. Vancomycin-associated acute kidney injury: a cross-sectional study from a single center in China. PLoS One. 2017;12(4):e0175688. https:\/\/doi.org\/10.1371\/journal.pone.0175688.","journal-title":"PLoS One"},{"issue":"11","key":"2512_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1525-1497.1998.00224.x","volume":"13","author":"DL Paterson","year":"1998","unstructured":"Paterson DL, Robson JM, Wagener MM. Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med. 1998;13(11):735\u20139. https:\/\/doi.org\/10.1046\/j.1525-1497.1998.00224.x.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2512_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/qjmed\/95.5.291","volume":"95","author":"D Raveh","year":"2002","unstructured":"Raveh D, Kopyt M, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. QJM. 2002;95(5):291\u20137. https:\/\/doi.org\/10.1093\/qjmed\/95.5.291.","journal-title":"QJM."},{"issue":"1","key":"2512_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12941-018-0262-0","volume":"17","author":"R Aggarwal","year":"2018","unstructured":"Aggarwal R, Dewan A. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study. Ann Clin Microbiol Antimicrob. 2018;17(1):15. https:\/\/doi.org\/10.1186\/s12941-018-0262-0.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"2512_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1248\/yakushi.17-00002","volume":"137","author":"T Morimoto","year":"2017","unstructured":"Morimoto T, Nagashima H, Morimoto Y, Tokuyama S. Frequency of acute kidney injury caused by Tazobactam\/Piperacillin in patients with pneumonia and chronic kidney disease: a retrospective observational study. Yakugaku Zasshi. 2017;137(9):1129\u201336. https:\/\/doi.org\/10.1248\/yakushi.17-00002.","journal-title":"Yakugaku Zasshi"},{"issue":"1","key":"2512_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/MJT.0b013e31818f9eae","volume":"17","author":"P Baghaei","year":"2010","unstructured":"Baghaei P, Tabarsi P, Chitsaz E, Saleh M, Marjani M, Shemirani S, et al. Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. Am J Ther. 2010;17(1):17\u201322. https:\/\/doi.org\/10.1097\/MJT.0b013e31818f9eae.","journal-title":"Am J Ther"},{"issue":"1","key":"2512_CR34","doi-asserted-by":"publisher","first-page":"FC09","DOI":"10.7860\/JCDR\/2016\/15621.7099","volume":"10","author":"VP Giri","year":"2016","unstructured":"Giri VP, Giri OP, Bajracharya S, Khan FA, Sinha SP, Kanodia S, et al. Risk of acute kidney injury with amikacin versus gentamycin both in combination with metronidazole for surgical prophylaxis. J Clin Diagn Res. 2016;10(1):FC09\u201312. https:\/\/doi.org\/10.7860\/JCDR\/2016\/15621.7099.","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"2512_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/ajag.12541","volume":"37","author":"CS Sia","year":"2018","unstructured":"Sia CS, Ananda-Rajah MR, Adler NR, Yi-Wei B, Liew D, Tong EY, et al. Renal safety of short-term empiric gentamicin therapy in aged patients. Australas J Ageing. 2018;37(3):227\u201331. https:\/\/doi.org\/10.1111\/ajag.12541.","journal-title":"Australas J Ageing"},{"issue":"12","key":"2512_CR36","doi-asserted-by":"publisher","first-page":"e034844","DOI":"10.1136\/bmjopen-2019-034844","volume":"10","author":"S Baik","year":"2020","unstructured":"Baik S, Lau J, Huser V, McDonald CJ. Association between tendon ruptures and use of fluoroquinolone, and other oral antibiotics: A 10-year retrospective study of 1 million US senior Medicare beneficiaries. BMJ Open. 2020;10(12):e034844.","journal-title":"BMJ Open"},{"issue":"3","key":"2512_CR37","doi-asserted-by":"publisher","first-page":"ofz039","DOI":"10.1093\/ofid\/ofz039","volume":"6","author":"H Ahmed","year":"2019","unstructured":"Ahmed H, Farewell D, Francis NA, Paranjothy S, Butler CC. Choice of Empirical Antibiotic Therapy and Adverse Outcomes in Older Adults With Suspected Urinary Tract Infection: Cohort Study. Open Forum Infect Dis. 2019;6(3):ofz039.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"2512_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00590-016-1794-7","volume":"26","author":"I Ahmed","year":"2016","unstructured":"Ahmed I, Khan MA, Allgar V, Mohsen A. The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery. Eur J Orthop Surg Traumatol. 2016;26(5):483\u201392. https:\/\/doi.org\/10.1007\/s00590-016-1794-7.","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"8","key":"2512_CR39","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/bcp.13594","volume":"84","author":"KM Pan","year":"2018","unstructured":"Pan KM, Wu Y, Chen C, Chen ZZ, Xu JA, Cao L, et al. Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-Centre cross-sectional study. Br J Clin Pharmacol. 2018;84(8):1706\u201318. https:\/\/doi.org\/10.1111\/bcp.13594.","journal-title":"Br J Clin Pharmacol"},{"key":"2512_CR40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jclinepi.2019.12.013","volume":"120","author":"A Moskalewicz","year":"2020","unstructured":"Moskalewicz A, Oremus M. No clear choice between Newcastle-Ottawa scale and appraisal tool for cross-sectional studies to assess methodological quality in cross-sectional studies of health-related quality of life and breast cancer. J Clin Epidemiol. 2020;120:94\u2013103. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.12.013.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2512_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/bcp.13439","volume":"84","author":"RS Hayward","year":"2018","unstructured":"Hayward RS, Harding J, Molloy R, Land L, Longcroft-Neal K, Moore D, et al. Adverse effects of a single dose of gentamicin in adults: a systematic review. Br J Clin Pharmacol. 2018;84(2):223\u201338. https:\/\/doi.org\/10.1111\/bcp.13439.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"2512_CR42","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2215\/CJN.05920616","volume":"11","author":"A Sinha Ray","year":"2016","unstructured":"Sinha Ray A, Haikal A, Hammoud KA, Yu AS. Vancomycin and the risk of AKI: a systematic review and Meta-analysis. Clin J Am Soc Nephrol. 2016;11(12):2132\u201340. https:\/\/doi.org\/10.2215\/CJN.05920616.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2512_CR43","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/qjmed\/hcp143","volume":"102","author":"NM Selby","year":"2009","unstructured":"Selby NM, Shaw S, Woodier N, Fluck RJ, Kolhe NV. Gentamicin-associated acute kidney injury. Qjm. 2009;102(12):873\u201380. https:\/\/doi.org\/10.1093\/qjmed\/hcp143.","journal-title":"Qjm."},{"issue":"7","key":"2512_CR44","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/AAC.01430-08","volume":"53","author":"JF Oliveira","year":"2009","unstructured":"Oliveira JF, Silva CA, Barbieri CD, Oliveira GM, Zanetta DM, Burdmann EA. Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob Agents Chemother. 2009;53(7):2887\u201391. https:\/\/doi.org\/10.1128\/AAC.01430-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2512_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000440867","volume":"131","author":"F Paquette","year":"2015","unstructured":"Paquette F, Bernier-Jean A, Brunette V, Ammann H, Lavergne V, Pichette V, et al. Acute kidney injury and renal recovery with the use of aminoglycosides: a large retrospective study. Nephron. 2015;131(3):153\u201360. https:\/\/doi.org\/10.1159\/000440867.","journal-title":"Nephron."},{"issue":"1","key":"2512_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13613-018-0373-y","volume":"8","author":"DY Fuhrman","year":"2018","unstructured":"Fuhrman DY, Kane-Gill S, Goldstein SL, Priyanka P, Kellum JA. Acute kidney injury epidemiology, risk factors, and outcomes in critically ill patients 16-25 years of age treated in an adult intensive care unit. Ann Intensive Care. 2018;8(1):26. https:\/\/doi.org\/10.1186\/s13613-018-0373-y.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"2512_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.20800","volume":"42","author":"E Bj\u00f6rnsson","year":"2005","unstructured":"Bj\u00f6rnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42(2):481\u20139. https:\/\/doi.org\/10.1002\/hep.20800.","journal-title":"Hepatology."},{"issue":"2","key":"2512_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","volume":"129","author":"RJ Andrade","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fern\u00e1ndez MC, Pelaez G, Pachkoria K, Garc\u00eda-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129(2):512\u201321. https:\/\/doi.org\/10.1016\/j.gastro.2005.05.006.","journal-title":"Gastroenterology."},{"issue":"11","key":"2512_CR49","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1038\/ajg.2010.287","volume":"105","author":"H Devarbhavi","year":"2010","unstructured":"Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol. 2010;105(11):2396\u2013404. https:\/\/doi.org\/10.1038\/ajg.2010.287.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2512_CR50","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015;148(7):1340\u201352.e7.","journal-title":"Gastroenterology"},{"issue":"2","key":"2512_CR51","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/hep.28323","volume":"63","author":"ES Bj\u00f6rnsson","year":"2016","unstructured":"Bj\u00f6rnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports. Hepatology. 2016;63(2):590\u2013603. https:\/\/doi.org\/10.1002\/hep.28323.","journal-title":"Hepatology."},{"issue":"2","key":"2512_CR52","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01568-12","volume":"57","author":"SJ van Hal","year":"2013","unstructured":"van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013;57(2):734\u201344. https:\/\/doi.org\/10.1128\/AAC.01568-12.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2512_CR53","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1365-2753.2008.00986.x","volume":"14","author":"JP Ioannidis","year":"2008","unstructured":"Ioannidis JP. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008;14(5):951\u20137. https:\/\/doi.org\/10.1111\/j.1365-2753.2008.00986.x.","journal-title":"J Eval Clin Pract"},{"issue":"2","key":"2512_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193\u2013206. https:\/\/doi.org\/10.1037\/1082-989X.11.2.193.","journal-title":"Psychol Methods"},{"issue":"2","key":"2512_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97\u2013111. https:\/\/doi.org\/10.1002\/jrsm.12.","journal-title":"Res Synth Methods"},{"issue":"2","key":"2512_CR56","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ajodo.2019.10.007","volume":"157","author":"LM Spineli","year":"2020","unstructured":"Spineli LM, Pandis N. Meta-analysis: random-effects model. Am J Orthod Dentofac Orthop. 2020;157(2):280\u20132. https:\/\/doi.org\/10.1016\/j.ajodo.2019.10.007.","journal-title":"Am J Orthod Dentofac Orthop"},{"issue":"23","key":"2512_CR57","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.0b013e318258f812","volume":"78","author":"WA Kukull","year":"2012","unstructured":"Kukull WA, Ganguli M. Generalizability: the trees, the forest, and the low-hanging fruit. Neurology. 2012;78(23):1886\u201391. https:\/\/doi.org\/10.1212\/WNL.0b013e318258f812.","journal-title":"Neurology."}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-021-02512-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-021-02512-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-021-02512-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T17:03:49Z","timestamp":1635786229000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-021-02512-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1186\/s12877-021-02512-3","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"617"}}